netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Lenvatinib found 10 matches
Open monograph to display formulary status BNF Category
  Lenvatinib  (Kisplyx®) Malignant disease and immunosuppression - Protein kinase inhibitors - 08.01.05
  Cytotoxic Drug Pembrolizumab  (Keytruda®) Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
  Selpercatinib Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA 535: Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine (08.01.05)
link in drug section NICE TA 535: Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine (08.01.05)
link in drug section NICE TA 551: Lenvatinib for untreated advanced hepatocellular carcinoma (08.01.05)
link in drug section NICE TA498: Lenvatinib with everolimus for previously treated advanced renal cell carcinoma (08.01.05)
link in drug section NICE TA498: Lenvatinib with everolimus for previously treated advanced renal cell carcinoma (08.01.05)
link in drug section NICE TA858: Lenvatinib with pembrolizumab for untreated advanced renal cell carcinoma (08.01.05)
link in drug section NICE TA904: Pembrolizumab with lenvatinib for previously treated advanced or recurrent endometrial cancer (08.01.05)


 
netFormulary